Robert W. Ross - Jun 15, 2022 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Chris Frankenfield, Attorney-in-Fact
Stock symbol
XLO
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
3
Date filed
6/17/2022, 04:06 PM
Previous filing
Mar 3, 2022
Next filing
Aug 5, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney